or Try an Advanced Search...

    Stage Biopharmaceutical Stocks List

    Symbol Grade Name % Change
    ALGS F Aligos Therapeutics, Inc. -1.13
    ONCY D Oncolytics Biotech Inc. -0.90
    ENTO F Entero Therapeutics Inc. -0.88
    MNOV D MediciNova, Inc. -0.70
    ACXP D Acurx Pharmaceuticals, Inc. -0.44
    IMTX D Immatics N.V. -0.36
    GMDA F Gamida Cell Ltd. 0.00
    PULM F Pulmatrix, Inc. 0.00
    HCWB F HCW Biologics Inc. 0.00
    CRVS C Corvus Pharmaceuticals, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - General
    Related Stock Lists: Biopharmaceutical Biotechnology Medicine Cancer Clinical Medicine Life Sciences Clinical Development Immune System Immunotherapies Medication Pharmacy Pulmonary Fibrosis Pulmonology Treatment Of Cancer Acute Myeloid Leukemia Adenosine Adoptive Cell Transfer Age Related Diseases Alcohol Alopecia Areata

    Related ETFs - A few ETFs which own one or more of the above listed Stage Biopharmaceutical stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 1.16
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 0.86
    GINN A Goldman Sachs Innovate Equity ETF 0.07
    FPXE A First Trust IPOX Europe Equity Opportunities ETF 0.05
    IWC B iShares Microcap ETF 0.05
    View all Stage Biopharmaceutical ETFs...
    Compare ETFs
    Compare BBC to IWC Compare GINN to FPXE Compare GINN to IWC

        Stage Biopharmaceutical Stocks Recent News

        Date Stock Title
        May 20 ENTO Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference
        May 20 MNOV MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer
        May 17 PULM Pulmatrix files for $95M mixed shelf
        May 16 ALGS After Plunging -13.71% in 4 Weeks, Here's Why the Trend Might Reverse for Aligos Therapeutics (ALGS)
        May 16 ENTO First Wave BioPharma changes name to Entero Therapeutics
        May 16 ENTO First Wave BioPharma Changes Name to Entero Therapeutics
        May 16 ONCY Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
        May 16 ACXP Acurx Pharmaceuticals Inc (ACXP) Q1 2024 Earnings Call Transcript Highlights: Key Financial and ...
        May 16 ACXP Q1 2024 Acurx Pharmaceuticals Inc Earnings Call
        May 15 HCWB HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights
        May 15 ACXP Acurx Pharmaceuticals, Inc. (ACXP) Q1 2024 Earnings Call Transcript
        May 15 PULM Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100)
        May 15 ACXP Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection
        May 15 ACXP Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update
        May 15 ONCY Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial
        May 15 ACXP Acurx Pharmaceuticals GAAP EPS of -$0.28 misses by $0.04
        May 14 IMTX Immatics reports Q1 results
        May 14 IMTX Immatics Announces First Quarter 2024 Financial Results and Business Update
        May 14 MNOV MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome
        Related Industries: Biotechnology Drug Manufacturers - General
        Related Stock Lists: Biopharmaceutical Biotechnology Medicine Cancer Clinical Medicine Life Sciences Clinical Development Immune System Immunotherapies Medication Pharmacy Pulmonary Fibrosis Pulmonology Treatment Of Cancer Acute Myeloid Leukemia Adenosine Adoptive Cell Transfer Age Related Diseases Alcohol Alopecia Areata
        Stage Biopharmaceutical

        Browse All Tags